Find patient medical information for Austedo (deutetrabenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings, Austedo (deutetrabenazine) is an oral prescription medication approved to treat Huntington’s chorea and tardive dyskinesia (TD). Austedo is classified as a vesicular monoamine transporter 2 (VMAT2) inhibitor., The management of NMS should include (1) immediate discontinuation of AUSTEDO XR and AUSTEDO; (2) intensive symptomatic treatment and medical monitoring; and (3) treatment of any concomitant serious medical problems for which specific treatments are available., Once-daily Austedo XR has been shown to be therapeutically equivalent to the twice-daily formulation, providing another effective treatment choice. Other medicines approved to treat tardive dyskinesia include Ingrezza (valbenazine). This is not all the information you need to know about Austedo (deutetrabenazine) for safe and effective use., The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia and chorea associated with Huntington disease (HD)., Austedo is used to treat certain movement disorders. Find out what the recommended dosages are, how to take the drug, and more..